Close Menu

A Dow Jones Newswires story covers personalized medicine with profiles of companies, including Sequenom and Helicos, that push diagnostic tests for biomarkers. It's the expected growth in this arena that led to Invitrogen's $6.7 billion acquisition of Applied Biosystems, the article says; more deals are likely in the offing. The story quotes analyst Arthur Henderson as saying, "There is a lot of competition for deals; it is going to increase. ... The sky is the limit in terms of opportunity."

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

As the Canadian election season heats up, neither major party has really paid much attention to science, according to Nature News.

BBC News says the uncertainty over Brexit is affecting science funding in the UK.

A new app purports to tell users "how gay" they are by looking at their DNA, but experts tell Futurism that the app is bunk.

In Nature this week: human and great ape cerebral organoids reveal aspects of brain development unique to humans, and more.